ALAB 10-K Annual Reports

Astera Labs, Inc. - 2 annual reports

Astera Labs, Inc. Annual Report, Year Ended Dec 31, 2025

Feb 20, 2026

Astera Labs, Inc. (ALAB) demonstrated significant financial performance for the year ending December 31, 2025, with revenue soaring to $852.5 million, a substantial 115% increase from the prior year. This robust growth was driven by strong demand across its product lines, particularly Aries, Scorpio, and Taurus, alongside improved average selling prices. The company achieved a net income of $219.1 million, a dramatic turnaround from the net loss of $83.4 million in 2024, signaling strong operational improvements and market traction. Despite a slight decrease in gross margin to 75.7% due to a shift in product mix towards hardware modules, the company effectively managed operating expenses, which decreased by 7% year-over-year primarily due to a significant reduction in non-cash stock-based compensation. Astera Labs continues to invest heavily in research and development, with expenses increasing by 51% to support innovation in its Intelligent Connectivity Platform for cloud and AI infrastructure. The company's strong cash position and positive operating cash flow provide a solid foundation for continued growth and investment in its core technologies.

Astera Labs, Inc. Annual Report, Year Ended Dec 31, 2024

Feb 14, 2025

Astera Labs, Inc. (ALAB) has demonstrated exceptional revenue growth in fiscal year 2024, with a 242% increase compared to 2023, reaching $396.3 million. This surge is primarily driven by increased unit shipments of their Aries products and a more favorable product mix leading to higher average selling prices. The company has also significantly improved its gross margin, climbing to 76.4% in 2024 from 68.9% in 2023, largely due to reduced inventory write-downs. Despite the strong top-line performance, Astera Labs continues to operate at a net loss, which widened in 2024 to $83.4 million from $26.3 million in 2023. This increased loss is significantly influenced by a substantial rise in operating expenses, particularly non-cash stock-based compensation, which surged by $223.1 million related to RSUs vesting upon their IPO. The company's robust cash position, bolstered by the March 2024 IPO which generated $672.2 million in net proceeds, provides ample liquidity to fund operations and future investments. Astera Labs expects its current cash resources to be sufficient for at least the next 12 months.